Literature DB >> 7910534

Echinococcus multilocularis: parasite-specific humoral and cellular immune response subsets in mouse strains susceptible (AKR, C57B1/6J) or 'resistant' (C57B1/10) to secondary alveolar echinococcosis.

B Gottstein1, E Wunderlin, I Tanner.   

Abstract

Parasite-specific humoral and cell-mediated immune responses were investigated in highly susceptible (AKR and C57B1/6J) and relatively resistant (C57B1/10) mice undergoing secondary alveolar echinococcosis (infection with Echinococcus multilocularis metacestode). The parasite-specific proliferative immune response of lymph node cells upon in vitro antigen stimulation remained weak in all three mouse strains. By day 30 p.i., CD4+ lymphoblast cells dominated the total population of blast cells in all three mouse strains. There was, however, an unexpectedly high proportion of CD8+ blast cells; by day 90 p.i., a marked proportional increase in CD8+ cells was seen in susceptible (AKR and C57B1/6J), but not in resistant (C57B1/10) mice. Susceptible, but not resistant mice exhibited a significantly decreased responsiveness of lymph node cells to concanavalin A (Con A) stimulation on day 90 p.i. Analysis of the humoral immune response by ELISA showed that resistance in C57B1/10 mice was associated with the ability of the host to synthesize antibodies to Em2 of the IgG3 and IgG1 isotype. Em2 is a lectin-binding carbohydrate antigen of the laminated layer. In susceptible AKR and C57B1/6J mice, low levels of anti-Em2 antibodies of the IgG2a isotype were detected. Anti-Em2 antibodies of the IgG3/IgG1 isotype, however, were absent. Differences in subclass-specific IgG responses were confirmed by immunoblot analyses. Our findings suggest that differences in antigen recognition (with respect to subsets of humoral and cellular immune components), probably controlled by non-H-2 gene(s), coupled to immune suppression modulated by CD8+ cells and/or respective cytokines, may determine susceptibility or resistance in experimental infection with E. multilocularis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910534      PMCID: PMC1534874          DOI: 10.1111/j.1365-2249.1994.tb06549.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

Review 1.  Cytokines and Ig switching: evolutionary divergence between mice and humans.

Authors:  R E Callard; M W Turner
Journal:  Immunol Today       Date:  1990-06

2.  Echinococcus multilocularis: susceptibility and responses to infection in inbred mice.

Authors:  W K Kroeze; C E Tanner
Journal:  Int J Parasitol       Date:  1987-04       Impact factor: 3.981

3.  Cellular immunity in experimental Echinococcus multilocularis infection. II. Sequential and comparative phenotypic study of the periparasitic mononuclear cells in resistant and sensitive mice.

Authors:  S Bresson-Hadni; M Liance; J P Meyer; R Houin; J L Bresson; D A Vuitton
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

4.  Cellular immunity in experimental Echinococcus multilocularis infection. I. Sequential and comparative study of specific in vivo delayed-type hypersensitivity against E. multilocularis antigens in resistant and sensitive mice.

Authors:  M Liance; S Bresson-Hadni; J P Meyer; R Houin; D A Vuitton
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

5.  Em2-ELISA for the follow-up of alveolar echinococcosis after complete surgical resection of liver lesions.

Authors:  B Gottstein; K Tschudi; J Eckert; R Ammann
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 May-Jun       Impact factor: 2.184

6.  Cellular immune response in Echinococcus multilocularis infection in humans. II. Natural killer cell activity and cell subpopulations in the blood and in the periparasitic granuloma of patients with alveolar echinococcosis.

Authors:  D A Vuitton; S Bresson-Hadni; L Laroche; D Kaiserlian; S Guerret-Stocker; J L Bresson; M Gillet
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

7.  Humoral and cellular immune response in mice and dogs induced by a recombinant Echinococcus multilocularis antigen produced by a Salmonella typhimurium vaccine strain.

Authors:  B Gottstein; N Müller; S J Cryz; M Vogel; I Tanner; T Seebeck
Journal:  Parasite Immunol       Date:  1990-03       Impact factor: 2.280

8.  Comparison of serologic tests for the diagnosis and follow-up of alveolar hydatid disease.

Authors:  A P Lanier; D E Trujillo; P M Schantz; J F Wilson; B Gottstein; B J McMahon
Journal:  Am J Trop Med Hyg       Date:  1987-11       Impact factor: 2.345

9.  A monoclonal antibody against Echinococcus multilocularis Em2 antigen.

Authors:  P Deplazes; B Gottstein
Journal:  Parasitology       Date:  1991-08       Impact factor: 3.234

10.  Immune suppression induced by protoscoleces of Echinococcus multilocularis in mice. Evidence for the presence of CD8dull suppressor cells in spleens of mice intraperitoneally infected with E. multilocularis.

Authors:  T Kizaki; S Kobayashi; K Ogasawara; N K Day; R A Good; K Onoé
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

View more
  14 in total

1.  Major carbohydrate antigen of Echinococcus multilocularis induces an immunoglobulin G response independent of alphabeta+ CD4+ T cells.

Authors:  W J Dai; A Hemphill; A Waldvogel; K Ingold; P Deplazes; H Mossmann; B Gottstein
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

2.  Nitric oxide-mediated immunosuppression following murine Echinococcus multilocularis infection.

Authors:  W J Dai; B Gottstein
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

3.  Galα1-4Galβ1-3GalNAc is the dominant epitope of Em2 antigen, the mucin-type glycoprotein from Echinococcus multilocularis.

Authors:  Kimiaki Yamano; Akihiko Koizumi; Tadahiro Takeda; Fumiyuki Kiuchi; Noriyasu Hada
Journal:  Parasitol Res       Date:  2012-03-31       Impact factor: 2.289

4.  Inhibition of human peripheral blood mononuclear cell proliferative response by glycosphingolipids from metacestodes of Echinococcus multilocularis.

Authors:  F Persat; C Vincent; D Schmitt; M Mojon
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  Immunology and morphology studies on the proliferation of in vitro cultivated Echinococcus multilocularis metacestodes.

Authors:  A Hemphill; B Gottstein
Journal:  Parasitol Res       Date:  1995       Impact factor: 2.289

Review 6.  Echinococcus multilocularis and its intermediate host: a model of parasite-host interplay.

Authors:  Dominique Angèle Vuitton; Bruno Gottstein
Journal:  J Biomed Biotechnol       Date:  2010-03-21

7.  Echinococcus multilocularis proliferation in mice and respective parasite 14-3-3 gene expression is mainly controlled by an alphabeta CD4 T-cell-mediated immune response.

Authors:  Wen Juan Dai; Andreas Waldvogel; Mar Siles-Lucas; Bruno Gottstein
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

8.  Imunomodulative effect of liposomized muramyltripeptide phosphatidylethanolamine (L-MTP-PE) on mice with alveolar echinococcosis and treated with albendazole.

Authors:  Emília Dvoroznáková; Jarmila Porubcová; Viliam Snábel; Peter Fedorocko
Journal:  Parasitol Res       Date:  2008-06-29       Impact factor: 2.289

Review 9.  Echinococcosis and allergy.

Authors:  Dominique A Vuitton
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

10.  Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis.

Authors:  D Sturm; J Menzel; B Gottstein; P Kern
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.